Oscar Health (OSCR) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.49
- Estimate
- -$0.17
- Surprise
- +382.6%
- Revenue (period 2026-09-30)
- $6.3M
- Score today
- 6.8/10
Revenue source: xbrl.
How the report landed
Oscar Health (OSCR) beat the -$0.17 estimate with adjusted EPS of $0.49 — a large 382.6% upside surprise.
Coverage in the report window
- Piper Sandler Maintains Overweight on Oscar Health, Lowers Price Target to $45 — benzinga, 2026-11-06
Where TrendMatrix's rating stands now
TrendMatrix currently rates OSCR Hold at 6.8/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +382.6% surprise compares with a +156.3% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Healthcare gov-payer cliff: 93% of revenue from CMS premiums (≥70% threshold). CMS rate-change exposure dominates.
- Concentration risk — Customer: CMS premiums (93.0%)
- Concentration risk — Geographic: Florida
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $31.11
- Price target
- $31.67
- Stop
- $28.94
- Upside to target
- +1.8%
- Reward-to-risk
- 0.1:1
At 14.7× trailing and 14.9× forward earnings, consensus estimates imply little change in earnings power.
Model outputs from TrendMatrix’s engine as of 2026-11-06 — shown for context, not personalized investment advice.
OSCR at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $10.24B
- P/E (fwd)
- 14.9
- P/E (ttm)
- 14.7
- 52-week range
- $10.69–$38.50
- Off 52-week high
- 19.2%
- RSI (14)
- 45
- Volume vs avg
- 0.54×
- Score today
- 6.8/10